Kay L, Finelli C, Aussedat J, Guarnieri C, Rossi A
Laboratoire de Physiologie Cellularie Cardiaque, Université Joseph Fourier, Grenoble, France.
Am J Cardiol. 1995 Aug 24;76(6):45B-49B.
Rat hearts, arrested in situ after intracaval injection of a cardioplegic solution, were preserved for 15 hours at 4 degrees C either by simple immersion or by low-flow (0.3 mL/min) perfusion. After preservation under both conditions, the left ventricular pressure developed by the reperfused hearts reached 8% and 43% of the control value (80 mm Hg), respectively. The addition of trimetazidine (TMZ; 10(-6) M) to the cardioplegic solution induced an improvement in functional recovery (by 2.4 and 1.5, respectively). This effect of TMZ was accompanied by a better energy profile illustrated by a 2-fold increase in the adenosine triphosphate to inorganic phosphate ratio and a reduction of intracellular acidosis as determined by 31P nuclear magnetic resonance spectroscopy. The function of the mitochondria (state 3, reduced nicotinamide-adenine dinucleotide [NADH] formation) isolated from the preserved hearts was significantly depressed in the stored hearts. The addition of TMZ to the cardioplegic solution partially protected oxoglutarate (and succinate) mitochondrial respiration and induced an increase in Ca2+ triggered NADH formation. These results show that the bioenergy status of the myocardial cell in isolated arrested stored rat heart is improved by the presence of TMZ in the preservation solution. Moreover, the experiments demonstrate that this effect includes protection of mitochondrial function and suggest that the drug could exert some control in the Ca2+ regulation of mitochondria.
通过腔静脉注射心脏停搏液使大鼠心脏原位停搏后,分别采用单纯浸泡或低流量(0.3 mL/分钟)灌注的方式在4℃下保存15小时。在这两种条件下保存后,再灌注心脏产生的左心室压力分别达到对照值(80 mmHg)的8%和43%。在心脏停搏液中添加曲美他嗪(TMZ;10^(-6) M)可使功能恢复得到改善(分别提高2.4倍和1.5倍)。TMZ的这种作用伴随着更好的能量状态,表现为三磷酸腺苷与无机磷酸的比值增加2倍,以及通过31P核磁共振波谱法测定的细胞内酸中毒减轻。从保存的心脏中分离出的线粒体功能(状态3,还原型烟酰胺腺嘌呤二核苷酸[NADH]形成)在储存的心脏中显著降低。在心脏停搏液中添加TMZ可部分保护线粒体的α-酮戊二酸(和琥珀酸)呼吸,并诱导Ca2+触发的NADH形成增加。这些结果表明,保存液中存在TMZ可改善离体停搏储存大鼠心脏中心肌细胞的生物能量状态。此外,实验表明这种作用包括对线粒体功能的保护,并提示该药物可能在线粒体的Ca2+调节中发挥一定的控制作用。